A group of colleagues examine a prototype.

the 360 Innovation Hub

Collaboration is the heart and soul of Medicines360

Our groundbreaking 360 Innovation Hub powers our mission to transform ideas into life-changing health innovations for women. It is here that we convene top minds and resources from all corners of the health ecosystem to pioneer solutions that have the potential to transform women’s health while delivering meaningful impact.

The breadth of our capabilities spans the entire lifecycle of health innovation, from concept to commercialization, in order to accelerate access to new innovations for all women.

Transforming Ideas into
Impactful Innovations

From concept to commercialization

Within our Innovation Hub, we identify critical health gaps that need to be addressed to maximize impact for all women, especially the underserved. Beginning with a women-centric design mindset from the earliest stages of product conceptualization, we incorporate innovation at every stage of the product lifecycle.

Product Development

Two colleagues discuss product development.

We have an innovative approach for obtaining approvals efficiently: we prioritize diversity, inclusivity, and feasibility of access for women from underserved and rural areas, in addition to safety and efficacy, in our clinical studies. Our team has decades of combined experience and success in bringing new products to market, and we provide the expertise needed to guide products through appropriate processes, ensuring compliance with all relevant regulations and standards.

Public-Private Healthcare Expertise

A patient talks to a doctor.

Too often within our healthcare systems, millions of individuals are left without access to equitable care. Medicines360 was founded on the belief that all women deserve access to the life-changing products they need, and this focus has contributed to our deep experience understanding and navigating both public and private health sectors.

Partnerships for Commercialization

Two colleagues conduct a meeting.

A successful product launch requires a well-defined market strategy. We work with our partners to develop go-to-market strategies that maximize the impact of each innovation, ensuring it is affordable and accessible to reach underserved women. We have a proven track record of getting innovations to women faster by working alongside our partners, with commercial success.

Post-Launch Support and Lifecycle Management

Two colleagues look at a computer monitor; one assists the other.

Our commitment to our partners doesn’t end at product launch. We provide ongoing support to ensure the continued success of our innovations, including lifecycle management, public-private market expansion, and customer feedback.

Global Reach through Partnerships

A group of people sitting at tables.

We believe collaboration is key to innovation. Our partnerships are built on a foundation of shared goals, high standards, and mutual benefit, allowing us to leverage the strengths of each partner to bring new health technologies to market.

We partner with global health organizations, nonprofits, and governmental bodies to ensure that our innovations may one day reach women in every corner of the world. Through these partnerships, we can navigate the complexities of different healthcare systems, ensuring that our products are accessible to those who need them most.

Innovating For tomorrow, today

While we are always open to hearing about novel health innovations that have the potential to substantially improve the lives of millions of women, the areas of particular focus for our organization today include:

A mother and daughter.

Maternal Health

Complications during pregnancy, childbirth, and the postpartum period remain significant causes of death, particularly in low-income and under-resourced areas. Innovative solutions, such as improved diagnostic tools and safer delivery methods, can dramatically reduce maternal and infant mortality rates. 

A nurse tends to a patient.

Cervical cancer remains one of the most common cancers among women worldwide—particularly in countries where screening and vaccination programs are less accessible—impacting an estimated 13,000 women in the US and over 650,000 women globally every year. Providing better access to screening and early detection technologies for cervical cancer is a critical area of focus for Medicines360*.

A doctor speaks with a patient.

Contraceptive care is at the heart of Medicines360’s founding mission of providing every woman with health autonomy, regardless of socioeconomic status. We continue to support the products we’ve already launched (Liletta® and Abivela™) while focusing renewed energy on identifying new effective contraceptive options.